Compare price, profitability, solvency, and SEC-reported financials side by side—before deciding which assumptions deserve a closer look.
FY 2024 · View financials
Decision snapshot: RVMD stock price vs PCH: inconclusive Relative valuation is incomplete for this pair. Review the available filing metrics before drawing a conclusion.
Quick read
Each company valued on the other's multiple, then compared with the market price.
Implied fair value · at PCH's multiple
Needs PCH P/S.
Implied fair value · at RVMD's multiple
Needs RVMD P/S.
Metric by metric
Price unavailable
Where each company leads, and how wide the gap is.
Growth lag
Pricing power
Operating leverage
Lower is better
Not comparable
Lower leverage
Statements
Core statements aligned to each company's latest fiscal year.
SEC periods: RVMD FY 2023 (ended Dec 31, 2023) · PCH FY 2024 (ended Dec 31, 2024). Fiscal years are not aligned.
Trendline
Seven fiscal years of revenue, earnings, and margins before underwriting a re-rating.
Price framework
Market cap plus debt, less cash.
Price framework
Discounted free cash flow, then bridged to a per-share price. Same assumptions applied to both companies.
Revolution Medicines, Inc. · implied price per share
Bear
$5.37
Base
$6.32
Bull
$7.27
POTLATCHDELTIC CORP · implied price per share
Bear
-$8.94
Base
-$10.52
Bull
-$12.10
Balance sheet health
Financial health checks to separate durable balance sheets from potential value traps.
Financial strength on a 0–9 scale.
Bankruptcy-risk signal from balance sheet and earnings power.
Not enough data to score either balance sheet.
Debt / equity
Total debt against shareholders' equity
0.39x
0.56x
Net debt / EBITDA
Leverage against operating earnings
1.24x
13.80x
Cash and equivalents
Liquid reserves on the balance sheet
$2.03B
$151.59M
Total debt
Interest-bearing obligations outstanding
Comparable set
Where the pair sits against the wider comparable set.
Keep comparing
Open adjacent comparisons from the same industry to pressure-test the read across multiple pairs.
AMGEN INC
RVMD vs AMGN
BRISTOL MYERS SQUIBB CO
RVMD vs BMY
GILEAD SCIENCES, INC.
RVMD vs GILD
INCYTE CORP
RVMD vs INCY
VERTEX PHARMACEUTICALS INC / MA
RVMD vs VRTX
Moderna, Inc.
RVMD vs MRNA
WEYERHAEUSER CO
RVMD vs WY
RAYONIER INC
RVMD vs RYN
SIMMONS FIRST NATIONAL CORP
RVMD vs SFNC
ANNALY CAPITAL MANAGEMENT INC
RVMD vs NLY
AGNC Investment Corp.
RVMD vs AGNC
$642.17M
$1.13B
Live quote
Live quote
LLM-powered synthesis
An on-demand narrative read of the same deterministic data.
The deterministic comparison remains available. Sign in when you want an on-demand narrative synthesis of the same data.
